Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA061253-05S1
Application #
2683549
Study Section
Pathology B Study Section (PTHB)
Program Officer
Freeman, Colette S
Project Start
1993-07-01
Project End
2000-06-30
Budget Start
1997-09-09
Budget End
1998-06-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Lamb, Justin; Ramaswamy, Sridhar; Ford, Heide L et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-34
Fournier, Marcia V; Martin, Katherine J; Graner, Edgard et al. (2003) Sensitive assays for detection of lung cancer. Molecular markers in blood samples. Methods Mol Med 75:239-50
Sotiropoulou, Georgia; Kono, Mari; Anisowicz, Anthony et al. (2002) Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer. Mol Med 8:42-55
Biswas, D K; Cruz, A; Pettit, N et al. (2001) A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Mol Med 7:59-67
Martin, K J; Graner, E; Li, Y et al. (2001) High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A 98:2646-51
Fournier, M V; Martin, K J; Pardee, A B (2001) Solid tumor cancer markers and applications to steroid hormone research. Methods Mol Biol 176:329-40
McGowen, R; Biliran Jr, H; Sager, R et al. (2000) The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60:4771-8
Biswas, D K; Cruz, A P; Gansberger, E et al. (2000) Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A 97:8542-7
Huang, L; Sowa, Y; Sakai, T et al. (2000) Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene 19:5712-9
Biswas, D K; Cruz, A P; Pardee, A B (2000) Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assays. Biotechniques 29:1056-60, 1062-4

Showing the most recent 10 out of 35 publications